November 2023
184 articles-
Nov 29 · 22:20Biotechnology Daily
Beacon Biosignals lights the way to FDA nod for AI-powered sleep monitoring headset
-
Nov 29 · 22:19Biotechnology Daily
Mayo Clinic, GE HealthCare launch tech-driven theranostic imaging collaboration
-
Nov 29 · 22:18Biotechnology Daily
MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
-
Nov 29 · 22:17Biotechnology Daily
FDA clears wearable ECG patches from Samsung spinout Wellysis, SmartCardia
-
Nov 29 · 22:15Bio Business News
BioNTech secures $90M from CEPI to partner on mpox vaccine as it enters clinic
-
Nov 29 · 22:14Bio Business News
Nobel laureate Carolyn Bertozzi joins Acepodia as biotech aims to transform cancer cell therapy
-
Nov 29 · 22:12Bio Business News
Blackstone's $250M bet beats Xarelto in bleeding trial, making case for Anthos' ex-Novartis asset
-
Nov 29 · 22:11Bio Business News
RayzeBio overshoots expectations with $311M IPO while Neumora hits $250M target
-
Nov 28 · 21:39Biotechnology Daily
Delayed TIL 2024: FDA resource constraints push back decision on Iovance cell therapy
-
Nov 28 · 21:38Biotechnology Daily
As White House mulls microbe research, microbiologists chime in with calls for standardized practices
-
Nov 28 · 21:37Biotechnology Daily
BMS trims anti-TIGIT pipeline and a handful of other early- to midstage meds
-
Nov 28 · 21:36Biotechnology Daily
Mammogram AI shows more promise, performing as well as radiologists in breast cancer screening study
-
Nov 28 · 21:34Bio Business News
Rise and shine: AWAK Technologies takes in $20M for portable dialysis system
-
Nov 28 · 21:33Bio Business News
Carl June, Vertex execs and Parkinson's scientists win Breakthrough prizes
-
Nov 28 · 21:32Bio Business News
Akili cuts workforce another 40%, pivots to selling digital therapeutics over the counter
-
Nov 28 · 21:31Bio Business News
AbbVie cuts ties to Harpoon’s BCMA trispecific, puncturing dream of $200M payday
-
Nov 27 · 22:04Biotechnology Daily
Sanofi slings long-dormant Alzheimer's asset to First Wave for repurposing, secures buy back rights
-
Nov 27 · 22:03Biotechnology Daily
NeurAxis neuromod therapy improves symptoms for teens with painful GI disorders: study
-
Nov 27 · 22:02Biotechnology Daily
Backed by space-age tech, MRI-compatible biopsy robot earns FDA clearance
-
Nov 27 · 22:01Biotechnology Daily
Smooth sailing for Madrigal as NASH candidate gets FDA priority review, no AdComm
-
Nov 27 · 22:00Bio Business News
Hemogenyx gears up to get CAR-T into clinic as FDA approves plan to address hold concerns
-
Nov 27 · 21:59Bio Business News
Generate raises $273M—$100M less than previous round—but a huge bounty
-
Nov 27 · 21:58Bio Business News
Moderna follows AstraZeneca's lead, dumping 2 previously shared programs—plus 2 more
-
Nov 27 · 21:57Bio Business News
Canadian CRO Cirion Biopharma acquired by French diagnostic group Cerba HealthCare